Wednesday, July 4, 2018

ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer.


from Reuters: Health News https://ift.tt/2lRTM6V

Related Posts:

  • LATEST HEALTH NEWSCongo Republic on Saturday confirmed its first case of the coronavirus, a 50-year-old man who had traveled to the country on March 1 from Paris, the government said. from Reuters: Health News https://ift.tt/2Qg85S1 … Read More
  • LATEST HEALTH NEWSA clinical trial to evaluate a vaccine designed to protect against the new coronavirus will begin on Monday, the Associated Press reported, citing an unnamed U.S. government official. from Reuters: Health News https://if… Read More
  • LATEST HEALTH NEWSEstonia will stop foreign traveler from entering the country from March 17, in an attempt to prevent the spread of coronavirus, the country's government said in a statement on Sunday. from Reuters: Health News https://if… Read More
  • LATEST HEALTH NEWSFrom Disneyland to the U.S. Supreme Court, from Wall Street to Dodgers Stadium, nearly every facet of American life fell into turmoil on Thursday as the coronavirus outbreak forced sweeping closures and economic disruption. … Read More
  • LATEST HEALTH NEWSBritain's food retailers appealed to shoppers on Sunday to stop panic buying during the coronavirus outbreak, saying purchasing more than they need would mean others will be left without. from Reuters: Health News https:… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner